InvestSMART

ImpediMed Limited (ASX: IPD) - Announcements

Current share price for IPD : $0.005 0.001 (16.67%)+

ASX company news and announcements for ImpediMed Limited (IPD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ImpediMed Limited (IPD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ImpediMed Limited (IPD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ImpediMed Limited (IPD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Underwritten Entitlement Offer 13 Nov 2014 10:02AM $0.690 $0.005 fallen by 99.28%
$18 Trading Halt 11 Nov 2014 10:03AM $0.690 $0.005 fallen by 99.28%
$18 Medicare payment for new L-Dex Category I code announced 3 Nov 2014 8:20AM $0.770 $0.005 fallen by 99.35%
$18 Appendix 4C - quarterly 27 Oct 2014 8:27AM $0.710 $0.005 fallen by 99.30%
$18 L-Dex granted reimbursement status for all cancer related Ly 3 Sep 2014 10:53AM $0.510 $0.005 fallen by 99.02%
$18 Trading Halt 3 Sep 2014 9:02AM $0.510 $0.005 fallen by 99.02%
$18 Preliminary Final Report 27 Aug 2014 9:06AM $0.410 $0.005 fallen by 98.78%
$18 Appendix 4C - quarterly 30 Jul 2014 12:42PM $0.300 $0.005 fallen by 98.33%
$18 Macquarie University Cancer Institute L-Dex Trial Site 23 Jul 2014 8:29AM $0.270 $0.005 fallen by 98.15%
$18 International Post-approval Clinical Trial commences 26 Jun 2014 9:15AM $0.185 $0.005 fallen by 97.30%
$18 Appendix 4C - quarterly 22 Apr 2014 8:30AM $0.215 $0.005 fallen by 97.67%
$18 Successful A$8.8 Million Placement 28 Mar 2014 8:59AM $0.240 $0.005 fallen by 97.92%
$18 Trading Halt 26 Mar 2014 9:31AM $0.220 $0.005 fallen by 97.73%
$18 Half Yearly Report and Accounts 26 Feb 2014 2:16PM $0.235 $0.005 fallen by 97.87%
$18 Appendix 4C - quarterly 28 Jan 2014 9:33AM $0.235 $0.005 fallen by 97.87%
$18 Nutrition and Body Composition 17 Dec 2013 8:32AM $0.250 $0.005 fallen by 98%
$18 Curie Clinical Trial Service Agreement signed 28 Nov 2013 12:31PM $0.260 $0.005 fallen by 98.08%
$18 AMA accepts Category 1 CPT Code 13 Nov 2013 8:36AM $0.225 $0.005 fallen by 97.78%
$18 Appendix 4C - quarterly 24 Oct 2013 1:51PM $0.170 $0.005 fallen by 97.06%
$18 Large US Healthcare Provider expands L-Dex use 9 Oct 2013 10:12AM $0.175 $0.005 fallen by 97.14%
$18 Preliminary Final Report 28 Aug 2013 8:24AM $0.160 $0.005 fallen by 96.88%
$18 Appendix 4C - quarterly 23 Jul 2013 8:43AM $0.145 $0.005 fallen by 96.55%
$18 Response to ASX Price Query 19 Jun 2013 10:04AM $0.115 $0.005 fallen by 95.65%
$18 Key Milestone 510(k) Clearance Received 7 Jun 2013 8:28AM $0.065 $0.005 fallen by 92.31%
$18 Appendix 4C - quarterly 22 Apr 2013 8:29AM $0.065 $0.005 fallen by 92.31%

1101 - 1125 of 1207 results

Page 45 of 49

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.